article thumbnail

MI, HF, and Oncologic Outcomes in Breast Cancer Survivors

American College of Cardiology

Does the development of cardiovascular (CV) events, specifically myocardial infarction (MI) or heart failure (HF), in breast cancer survivors influence their oncologic outcomes?

Cancer 61
article thumbnail

Abstract 4145554: Obstructive Sleep Apnea Increases the Risk of Cardiovascular Disease and Stroke Among Persons with Cancer: Analyses from a Multi-center Electronic Healthcare Records-Based Database.

Circulation

Adverse CVD outcomes was defined as a composite of incident heart failure, incident atrial fibrillation / flutter, incident myocardial infarction or all-cause mortality. Patients were eligible to enter the cohort on the day of cancer diagnosis. The table shows the demographic and comorbidities of the matched groups.

Cancer 40
article thumbnail

Effect of Intensive Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors

Hypertension Journal

Using Cox proportional hazards regression, we tested interactions between history of cancer and intensive blood pressure control on major cardiovascular outcomes.RESULTS:The study included a total of 9336 patients, with a mean age of 67.9±9.4 years, among whom 2066 (22.2%) were cancer survivors. Hypertension, Ahead of Print.

article thumbnail

Small extracellular vesicles from the infarcted heart can promote tumour growth

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 02 April 2024; doi:10.1038/s41569-024-01022-0 After myocardial infarction, the heart secretes small extracellular vesicles with pro-neoplastic properties that can accelerate tumour growth when taken up by cancer cells.

article thumbnail

Cardiopulmonary exercise testing for cardiovascular risk assessment in patients undergoing gastric and oesophageal cancer surgery: results from a prospective interventional cohort study

Open Heart

However, data about the predictive value of CPET for cardiovascular outcome after gastric or oesophageal cancer surgery are inconclusive. Methods This is a prospective single-centre interventional cohort study including 200 consecutive patients who underwent elective surgery for oesophageal and/or gastric cancer. An AT level <9.5

Cancer 52
article thumbnail

Superfamily II helicases: the potential therapeutic target for cardiovascular diseases

Frontiers in Cardiovascular Medicine

However, abnormal helicase expression has been associated with immune response, cancer, and intellectual disability in humans. They play a pivotal role in gene expression, inflammatory response, lipid metabolism, and so forth. Superfamily II (SFII) is one of the largest and most diverse of the helicase superfamilies.

article thumbnail

Abstract 4148106: Hemophilia and Cardiovascular disease in the United States: Prevalence, Risk factors, and outcomes.

Circulation

The secondary outcomes comprise the odds of adverse events, including myocardial infarction, ischemic stroke, transient ischemic attack (TIA), occlusive atherosclerotic disease, percutaneous coronary intervention, and coronary artery bypass graft (CABG)., The hemophilia cohort was slightly older (63.2[16.8]